| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 01/31/1996 | EP0694070A1 Recombinant alphavirus vectors |
| 01/31/1996 | EP0694042A1 Inhibitor of vascular endothelial cell growth factor |
| 01/31/1996 | EP0694040A1 1,5 benzodiazepine derivatives having cck and/or gastrin antagonistic activity |
| 01/31/1996 | EP0694039A1 1,5-benzodiazepine derivatives having cck antagonistic or agonistic activity |
| 01/31/1996 | EP0693935A1 Method and compositions for digesting tissue |
| 01/31/1996 | EP0693933A1 Methods and compositions for delaying or preventing the onset of autoimmune disease |
| 01/31/1996 | EP0693931A1 Immunogenic cancer proteins and peptides and method of use |
| 01/31/1996 | EP0693925A1 Production of recombinant factor xa inhibitor of leech hirudo medicinalis |
| 01/31/1996 | EP0693921A1 Anti-oxidant alkylaryl polyether alcohol polymers |
| 01/31/1996 | EP0593557B1 Aromatic compounds, pharmaceutical compositions containing them and their use in therapy |
| 01/31/1996 | CN1115761A Derivative, preparation and medical application of quinoline and imidazole |
| 01/31/1996 | CA2154910A1 Method for the racemisation of enantiomers of .alpha.-lipoic acid |
| 01/30/1996 | US5488145 2,4-disulfonyl phenyl butyl nitrone, its salts, and their use as pharmaceutical free radical traps |
| 01/30/1996 | US5488062 2-saccharinylmethyl heterocyclic carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof |
| 01/30/1996 | US5488057 2-oxindole compounds which have useful tyrosine kinase activity |
| 01/30/1996 | US5488053 Tetrahydro-pyrido-indole |
| 01/30/1996 | US5488048 Aminoacetylmercapto derivatives useful as inhibitors of enkephalinase and ace |
| 01/30/1996 | US5488044 Method of treating metabolic bone disease with (E)-20(22)-dehydrovitamin D compounds |
| 01/30/1996 | US5488041 Method of promoting bone repair using tiludronic disodium salt |
| 01/30/1996 | US5487974 Contact blood samples and determine proliferation of cytolytic lymphocytes and lysis of cells presenting said complexes |
| 01/30/1996 | CA1338012C Pharmaceutically active amines |
| 01/25/1996 | WO1996002000A1 E6 binding proteins |
| 01/25/1996 | WO1996001896A1 Connective tissue growth factor-2 |
| 01/25/1996 | WO1996001847A1 Diagnostic methods and compositions relating to the proteoglycan proteins of cartilage breakdown |
| 01/25/1996 | WO1996001845A1 Growth differentiation factor-11 |
| 01/25/1996 | WO1996001842A1 Processes for the purification of human recombinant decorin and the detection of guanidinium ions |
| 01/25/1996 | WO1996001825A1 Heterobicyclic derivatives |
| 01/25/1996 | WO1996001824A1 Process for the preparation of 2-(1-azabicyclo(2.2.2)oct-3-yl) -2,4,5,6-tetrahydro-1h-benz(de)isoquinolin-1-one and intermediate product |
| 01/25/1996 | WO1996001819A1 Heterocyclic tachykinin receptor antagonists |
| 01/25/1996 | WO1996001817A1 Bicyclic amidine derivatives as inhibitors of nitric oxide synthetase |
| 01/25/1996 | WO1996001813A1 CONFORMATIONALLY RIGID BICYCLIC AND ADAMANTANE DERIVATIVES USEFUL AS α2-ADRENERGIC BLOCKING AGENTS |
| 01/25/1996 | WO1996001648A1 Attenuation of wound healing processes |
| 01/25/1996 | WO1996001644A1 Inhibitors of leukocyte adhesion |
| 01/25/1996 | WO1996001636A1 A method for the prophylaxis and/or treatment of proliferative and/or inflammatory skin disorders |
| 01/25/1996 | WO1996001632A1 Method and compound for the treatment of hair loss |
| 01/25/1996 | DE19526187A1 7-Diazo-beta-lactamderivate und Verfahren zu deren Herstellung 7-diazo-beta-lactam derivatives and process for their preparation |
| 01/25/1996 | CA2194872A1 Pyridopyrazine derivatives |
| 01/25/1996 | CA2194773A1 Method and compound for the treatment of hair loss |
| 01/25/1996 | CA2194702A1 Conformationally rigid bicyclic and adamantane derivatives useful as .alpha.2-adrenergic blocking agents |
| 01/25/1996 | CA2194566A1 Processes for the purification of human recombinant decorin and the detection of guanidinium ions |
| 01/25/1996 | CA2194366A1 A method for the prophylaxis and/or treatment of proliferative and/or inflammatory skin disorders |
| 01/25/1996 | CA2193508A1 Inhibitors of leukocyte adhesion |
| 01/25/1996 | CA2188680A1 Bicyclic amidine derivatives as inhibitors of nitric oxide synthetase |
| 01/24/1996 | EP0693489A1 Heterocyclic tachykinin receptor antagonists |
| 01/24/1996 | EP0693287A1 RNA cleaving or binding oligonucleotides |
| 01/24/1996 | EP0693286A1 Pharmaceutical composition comprising furin |
| 01/24/1996 | EP0693285A2 Pharmaceutical compositions containing a bisphosphonate and an anti-resorptive agent for inhibiting bone loss |
| 01/24/1996 | EP0693278A2 Combinations of vasoactive substances with fatty acids to prevent hair loss |
| 01/24/1996 | EP0693129A1 Method of inhibiting the transcription of genes |
| 01/24/1996 | EP0693059A1 Perhydroisoindole derivatives, preparation thereof and pharmaceutical compositions containing same |
| 01/24/1996 | EP0693054A1 Cycloalkylhydroxyureas and their use as lipoxygenase inhibitors |
| 01/24/1996 | EP0693053A1 Urea and amide derivatives and their use in the control of cell membrane potassium channels |
| 01/24/1996 | EP0693051A1 Cyclopentene derivatives as endothelin receptor antagonists |
| 01/24/1996 | EP0692972A1 Method for delivering beneficial compositions to hair follicles |
| 01/24/1996 | EP0692969A1 Method of treatment of diseases by deletion of t cells |
| 01/24/1996 | EP0692968A1 Urokinase plasminogen activator fragments |
| 01/24/1996 | EP0692965A1 Method and composition for treatment of osteoporosis |
| 01/24/1996 | EP0692962A1 Use of steroid antagonists for the therapy and prophylaxis of demential illnesses |
| 01/24/1996 | EP0692931A1 Synthetic matrix metalloprotease inhibitors and uses thereof |
| 01/24/1996 | EP0610334B1 Nonpeptidyl integrin inhibitors having specificity for the gpii b iii a receptor |
| 01/24/1996 | CN1030766C Method for preparing of serotonin 5HTIA agonists |
| 01/23/1996 | US5486623 Cysteine protease inhibitors containing heterocyclic leaving groups |
| 01/23/1996 | US5486612 N-benzyl dihydroindole LTD4 antagonists |
| 01/23/1996 | US5486541 For treating parkinson*s disease, memory disorders, alzheimer*s disease, depression or hyperactive syndrome |
| 01/23/1996 | US5486532 Adrenergic agonist |
| 01/23/1996 | US5486518 4-indolylpiperazinyl derivatives |
| 01/23/1996 | US5486515 2-fluoroalkyl-1,4-benzoxaxines as potassium channel mediators |
| 01/23/1996 | US5486513 2-substituted indane-2-mercaptoacetylamide derivatives useful as inhibitors or enkephalinase and ace |
| 01/23/1996 | CA2154414A1 Combination treatment for inhibiting bone loss |
| 01/23/1996 | CA2154403A1 A novel osteoblast proliferative factor |
| 01/23/1996 | CA2154116A1 1-aryl-2-acetamidopentanone derivatives for use as tachykinin receptor antagonists |
| 01/23/1996 | CA1337991C Basically substituted phenylacetonitriles, their preparation and drugs containing these compounds |
| 01/23/1996 | CA1337990C Substituted azetidinones as anti-inflammatory antidegenerative agents |
| 01/22/1996 | EP0700378A4 Compounds which release nitric oxide |
| 01/18/1996 | WO1996001322A1 Serum paraoxonase |
| 01/18/1996 | WO1996001318A1 Immunomodulators |
| 01/18/1996 | WO1996001316A1 NOVEL GROWTH OR DIFFERENTIATION FACTOR OF THE TGF-β FAMILY |
| 01/18/1996 | WO1996001253A2 Pla2 inhibitors and their use for inhibition of intestinal cholesterol absorption |
| 01/18/1996 | WO1996001125A1 Use of insulin and igf-i |
| 01/18/1996 | WO1996001122A1 Methods for modulating t cell responses by manipulating a common cytokine receptor gamma chain |
| 01/18/1996 | WO1996001121A1 Cancer therapy using lymphotoxin |
| 01/18/1996 | WO1996001110A2 Anti-hiv triple combination |
| 01/18/1996 | WO1996001108A1 Stereochemical wortmannin derivatives |
| 01/18/1996 | WO1996001098A1 Hair tonic preparation |
| 01/18/1996 | DE4424714A1 Neue chemische Verbindung, ihre Herstellung und ihre Verwendung als Arnzneistoff New chemical compound, their preparation and their use as Arnzneistoff |
| 01/18/1996 | DE4424713A1 Substituierte Benzamidine, ihre Herstellung und Verwendung als Arnzneistoffe Substituted benzamidines, their preparation and use as Arnzneistoffe |
| 01/18/1996 | DE4424577A1 Transporter protein for cationic xenobiotic(s) and pharmaceuticals, and related DNA and transformed cells |
| 01/18/1996 | CA2194390A1 Serum paraoxonase |
| 01/18/1996 | CA2194239A1 Methods for modulating t cell responses by manipulating a common cytokine receptor gamma chain |
| 01/18/1996 | CA2193963A1 Stereochemical wortmannin derivatives |
| 01/18/1996 | CA2193489A1 Anti-hiv triple combination |
| 01/18/1996 | CA2193226A1 Use of insulin and igf-i |
| 01/18/1996 | CA2191775A1 Pla2 inhibitors and their use for inhibition of intestinal cholesterol absorption |
| 01/18/1996 | CA2191696A1 Cancer therapy using lymphotoxin |
| 01/17/1996 | EP0692535A1 Oligonucleotides to inhibit the role of isoprenyl protein transferases |
| 01/17/1996 | EP0692484A1 Benzothiadiazine derivative process for its preparation and pharmaceutical compositions containing it |
| 01/17/1996 | EP0692472A1 Alpha-(4-chlorophenyl)- 4-(4-fluorophenylmethyl)-piperidine-1 -ethanol esters, their preparation and therapeutical use |
| 01/17/1996 | EP0692258A1 Periwinkle seed extract and composition containing it |
| 01/17/1996 | EP0692251A1 Use of methotrexate for the manufacture of a medicament for the treatment of lung capillary leak |
| 01/17/1996 | EP0692250A2 Formulations containing esculoside and the use thereof in the pharmaceutical and cosmetic fields |